Machin P J, Hurst D N, Bradshaw R M, Blaber L C, Burden D T, Fryer A D, Melarange R A, Shivdasani C
J Med Chem. 1983 Nov;26(11):1570-6. doi: 10.1021/jm00365a005.
A series of 4-substituted phenoxypropanolamines was prepared and examined for beta-adrenoceptor activity. Some of the compounds, especially the [4-[2-[[2-(4-fluorophenyl)ethyl] oxy]ethoxy]phenoxy]propanolamines (14, 15, and 24), showed potent beta 1-blockade with virtually no beta 2-blockade at doses over a 1000 times greater. The compounds also possessed partial agonist activity. Structure-activity relationships are discussed, and conclusions are drawn about the binding sites on beta-adrenoceptors.
制备了一系列4-取代苯氧基丙醇胺,并对其β-肾上腺素受体活性进行了研究。其中一些化合物,特别是[4-[2-[[2-(4-氟苯基)乙基]氧基]乙氧基]苯氧基]丙醇胺(14、15和24),在剂量超过1000倍以上时显示出强效的β1阻断作用,而几乎没有β2阻断作用。这些化合物还具有部分激动剂活性。讨论了构效关系,并得出了关于β-肾上腺素受体结合位点的结论。